echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > 16 batches of essential drugs are unqualified

    16 batches of essential drugs are unqualified

    • Last Update: 2013-05-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: www.healthnews.com.cn May 24, 2013, State Food and Drug Administration recently released the second issue of 2013 drug quality announcement According to the announcement, the General Administration of food and drug of the people's Republic of China has organized a sampling inspection of 2885 batches of samples of 11 national essential drug varieties such as Leonurus tablet and 7 other preparation varieties such as Xihuang Pill Among them, all the inspection items of 2865 batches of samples meet the requirements of the standard, and the qualified rate is 99.3% 16 batches of essential drugs do not meet the standard The 11 national basic drugs selected for this test are: motherwort tablets (granules), amoxicillin and clavulanate potassium dry suspension (granules, tablets), Baohe pills, Huodan pills, fosfomycin calcium tablets, tetanus antitoxin / tetanus immunoglobulin (f (ab '+') 2), Nimodipine Injection, hydrochlorothiazide tablets, vitamin C There are 1903 batches of injection, Yangyin Qingfei ointment (pill) and penicillin potassium (sodium) for injection Among them, 16 batches of products do not meet the requirements of the standard; Tonghua Great Wall Pharmaceutical Co., Ltd produces the most unqualified products of fosfomycin calcium tablets, up to 6 batches, and the unqualified drugs are sold to 9 provinces (regions and cities) of Shanxi, Chongqing, Liaoning, Hunan, Jilin, Gansu, Qinghai, Guangxi and Heilongjiang The seven other preparations for this sampling were: compound dibazazolylchlorothiazine capsule, erythromycin Ethylsuccinate tablet (dispersible tablet), cefdinir dispersible tablet (capsule), Xihuang Pill, Cefminox Sodium for injection, Dieda tablet, Shexiang Jiegu capsule, a total of 982 batches Among them, four batches of Cefminox Sodium for injection produced by Hainan meimeimeixilin biopharmaceutical Co., Ltd are unqualified At present, the food and drug regulatory authorities in the places where the samples are taken and where the production enterprises are located are investigating and punishing the unqualified drugs according to law.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.